BARD1 Life Sciences (BD1) Stock Price, News & Analysis

Company Overview

BARD1 Life Sciences Limited engages in the research, development, and commercialization of non-invasive diagnostic products for the early detection of cancer to enhance patient outcomes and save lives in Australia. Its cancer diagnostics portfolio includes commercialized hTERT test used as an adjunct to urine cytology testing; and diagnostic tests in development for ovarian, breast, lung, prostate, and pancreatic cancers. The company is also providing Molecular NET technology, including its EXO-NETTM product to capture and purify exosomes. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in Notting Hill, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 801,545 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BD1 Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of BARD1 Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BARD1 Life Sciences investors own include Vulcan Energy Resources (VUL), Splitit Payments (SPT), Meta Platforms (META), Lake Resources (LKE), Kalium Lakes (KLL) and Collins Foods (CKF).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: ASX:BD1
• CUSIP: N/A
• CIK: N/A
• Web: www.bard1.com
• Phone: 61 8 9381 9550
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 4.35
• Current Ratio: 3.87
• Quick Ratio: 3.58

Sales & Book Value

• Annual Sales: $1.27 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.33
• Book Value: A$0.36 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 92,018,704
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A